Cargando…
Stem cells or their exosomes: which is preferred in COVID-19 treatment?
It only took 8 months for the pneumonia caused by a previously unknown coronavirus to turn into a global pandemic of unprecedentedly far-reaching implications. Failure of the already discovered treatment measures opened up a new opportunity to evaluate the potentials of mesenchymal stem cells and th...
Autores principales: | Hosseini, Nashmin Fayazi, Dalirfardouei, Razieh, Aliramaei, Mohammad Reza, Najafi, Rezvan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765836/ https://www.ncbi.nlm.nih.gov/pubmed/35043287 http://dx.doi.org/10.1007/s10529-021-03209-8 |
Ejemplares similares
-
Stem Cell-Derived Exosomes: a New Strategy of Neurodegenerative Disease Treatment
por: Fayazi, Nashmin, et al.
Publicado: (2021) -
Osteogenic induction of menstrual blood mesenchymal stem cell by different Ferula species extracts
por: Dalirfardouei, Razieh, et al.
Publicado: (2021) -
The Potential Anti-Inflammatory Effects of Zerumbone in COVID-19 Patients
por: Dehghan, Razieh, et al.
Publicado: (2021) -
Reducing False Negative PCR Test for COVID-19
por: Bahreini, Fatemeh, et al.
Publicado: (2020) -
A novel formulation of Mtb72F DNA vaccine for immunization against tuberculosis
por: Dalirfardouei, Razieh, et al.
Publicado: (2020)